Literature DB >> 6145519

Neuroleptic malignant syndrome.

R Kurlan, R Hamill, I Shoulson.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6145519     DOI: 10.1097/00002826-198406000-00001

Source DB:  PubMed          Journal:  Clin Neuropharmacol        ISSN: 0362-5664            Impact factor:   1.592


× No keyword cloud information.
  11 in total

1.  Combined neuroleptic malignant syndrome and the central anticholinergic syndrome.

Authors:  D A Bennett
Journal:  J Neurol Neurosurg Psychiatry       Date:  1990-08       Impact factor: 10.154

2.  Haloperidol-induced neuroleptic malignant syndrome in a 67-year-old woman with parkinsonism.

Authors:  T C Ryken; A N Merrell
Journal:  West J Med       Date:  1989-09

3.  Neuroleptic malignant syndrome.

Authors:  T H Lee; L M Tang
Journal:  J Neurol       Date:  1988-05       Impact factor: 4.849

Review 4.  Neuroleptic malignant syndrome.

Authors:  G A Chaimowitz; U Gomes; S S Maze
Journal:  CMAJ       Date:  1988-01-01       Impact factor: 8.262

5.  Development of malignant hyperthermia obscured by cardiopulmonary bypass.

Authors:  R G MacGillivray; H Jann; E Vanker; L Gemmell; A E Mahomedy
Journal:  Can Anaesth Soc J       Date:  1986-07

Review 6.  Role of the intensive care unit in the management of the poisoned patient.

Authors:  P Kulling; H Persson
Journal:  Med Toxicol       Date:  1986 Sep-Oct

7.  Neuroleptic malignant syndrome: a complication of neuroleptics and cocaine abuse.

Authors:  M J Akpaffiong; P Ruiz
Journal:  Psychiatr Q       Date:  1991

Review 8.  Clinical management of neuroleptic malignant syndrome.

Authors:  V L Susman
Journal:  Psychiatr Q       Date:  2001

9.  Case reports of neuroleptic malignant syndrome in context of quetiapine use.

Authors:  Mark B Detweiler; Kelly Sullivan; Taral R Sharma; Kye Y Kim; Jonna G Detweiler
Journal:  Psychiatr Q       Date:  2013-12

Review 10.  Neuroleptic malignant syndrome.

Authors:  M S Jahan; A I Farooque; Z Wahid
Journal:  J Natl Med Assoc       Date:  1992-11       Impact factor: 1.798

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.